ResearchMoz.us

ResearchMoz is the one stop online destination to find and buy market research reports and Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

Wednesday, 24 June 2015

Global colorectal cancer drugs market to grow at a CAGR of 3.62% over the period 2014-2019

ResearchMoz.us include new market research report"Global Colorectal Cancer Drugs Market 2015-2019 " to its huge collection of research reports.


About Colorectal Cancer 

Colorectal cancer refers to malignancies that originate in the rectum or the colon. It is also known as bowel cancer. Formation of adenocarcinomas is the most common feature of colorectal cancer. The cancer starts as a polyp in the inner wall of the colon or rectum. These polyps can be benign or malignant. Colorectal cancer is the third most common cancer in the US. Some of the risk factors that can cause colorectal cancer are lifestyle changes, old age, genetic disorders, family history, and inflammatory bowel disease. Some of the symptoms of colorectal cancer are blood in stool, decrease in appetite, constipation, weight loss, nausea, bloating, and pelvic pain. Colorectal cancer can be classified into four broad stages. Colorectal cancer can be treated using surgical, chemotherapeutic, biologic, and radiation therapies.



Technavio's analysts forecast the global colorectal cancer drugs market to grow at a CAGR of 3.62% over the period 2014-2019.

Covered in this Report

This report covers the present scenario and the growth prospects of the global colorectal cancer drugs market for the period 2015-2019. To calculate the market size, the report considers revenue generated from sales of various drugs used in the treatment of colorectal cancer. 

Based on the type of molecule, the market is grouped into two categories:

Biologics
Small molecules


Based on the route of administration, the market is grouped into two categories:

Oral
Parenteral


This report covers the present scenario and the growth prospects of the global colorectal cancer drugs market for the period 2015-2019 in the following regions: 

Americas: The principal countries focused upon in this region are the US, Canada, Mexico, and Brazil
EMEA: The principal countries focused upon in this region are the UK, Germany, Italy, France, Spain, Israel, South Africa, Egypt, Sudan, Kuwait, Saudi Arabia, Qatar, and UAE. Germany, Italy, and the UK are the leading European countries in terms of elderly population
APAC: The principal countries focused upon in this region are Japan, China, Australia, Singapore, South Korea, and India. 



The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors as well as the competitive performances of their product portfolios in the market. In addition, it discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by vendors and the market at large, as well as the key trends that are emerging in the market.

Technavio's report, Global Colorectal Cancer Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, EMEA, and APAC; it also covers the global colorectal cancer drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

Americas 
APAC
EMEA


Key Vendors

Amgen
Bayer
Bristol-Myers Squibb
F. Hoffmann-La Roche
Merck Serono


Other Prominent Vendors

Accord Healthcare
Advenchen Laboratories
Aeterna Zentaris
AstraZeneca
Bavarian Nordic
Biothera
Boehringer Ingelheim
Daiichi Sankyo
Debiopharm
Eisai
Eli Lilly
Immodulon Therapeutics
Mologen
Mylan
Nektar Therapeutics
Oncothyreon
Otsuka Pharmaceutical
Precision Biologics
Sun Pharmaceutical
Symphogen
Taiho
Takeda
Teva
ThromboGenics
Xbiotech
Yakult Honsha 


Market Driver

Increase in population of patients
For a full, detailed list, view our report

All Latest Market Research Report @ http://www.researchmoz.us/latest-report.html

Key Questions Answered in this Report

What will the market size be in 2019 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?




For More Information Kindly Contact:
Email: sales@researchmoz.us 

0 comments:

Post a Comment